Free Trial

CERo Therapeutics (CEROW) Competitors

$0.02 +0.01 (+42.86%)
As of 05/21/2025 03:47 PM Eastern

CEROW vs. ATNFW, SXTPW, DRTSW, WENAW, APLMW, BCTXW, CDIOW, CTCXW, CELUW, and CINGW

Should you be buying CERo Therapeutics stock or one of its competitors? The main competitors of CERo Therapeutics include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), and Cingulate (CINGW). These companies are all part of the "biotechnology" industry.

CERo Therapeutics vs.

CERo Therapeutics (NASDAQ:CEROW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their community ranking, profitability, media sentiment, valuation, dividends, institutional ownership, earnings, risk and analyst recommendations.

Company Net Margins Return on Equity Return on Assets
CERo TherapeuticsN/A N/A N/A
180 Life Sciences N/A N/A N/A

CERo Therapeutics and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
CERo TherapeuticsN/AN/A
180 Life SciencesN/AN/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CERo TherapeuticsN/AN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

In the previous week, CERo Therapeutics' average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
CERo Therapeutics Neutral
180 Life Sciences Neutral

Summary

CERo Therapeutics and 180 Life Sciences tied by winning 0 of the 0 factors compared between the two stocks.

Get CERo Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CEROW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CEROW vs. The Competition

MetricCERo TherapeuticsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$129.28M$5.35B$8.38B
Dividend YieldN/A3.74%5.22%4.10%
P/E RatioN/A3.4526.8419.71
Price / SalesN/A4,234.32392.34117.39
Price / CashN/A13.1938.2534.62
Price / BookN/A33.126.794.50
Net IncomeN/A-$91.56M$3.23B$248.18M
7 Day PerformanceN/A3.79%4.07%1.14%
1 Month PerformanceN/A8.34%12.52%15.20%
1 Year PerformanceN/A100.36%16.83%6.56%

CERo Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CEROW
CERo Therapeutics
N/A$0.02
+42.9%
N/A-70.4%$0.00N/A0.008Positive News
ATNFW
180 Life Sciences
N/A$0.01
-5.1%
N/A+15.6%$0.00N/A0.007Gap Down
SXTPW
60 Degrees Pharmaceuticals
N/A$0.05
-8.8%
N/A-52.2%$0.00$607,574.000.002Positive News
DRTSW
Alpha Tau Medical
N/A$0.25
+3.3%
N/A+13.1%$0.00N/A0.0080Positive News
WENAW
Anew Medical
N/A$0.04
-0.3%
N/AN/A$0.00N/A0.00N/AGap Down
APLMW
Apollomics
N/A$0.02
+62.7%
N/A+50.0%$0.00N/A0.0059Positive News
Gap Up
High Trading Volume
BCTXW
BriaCell Therapeutics
N/A$0.10
-22.8%
N/A-82.5%$0.00N/A0.008
CDIOW
Cardio Diagnostics
N/A$0.02
+21.8%
N/A-76.0%$0.00$34,890.000.007Positive News
CTCXW
Carmell
N/A$0.03
+6.8%
N/AN/A$0.00$32,839.000.0014Gap Up
CELUW
Celularity
N/A$0.04
-22.0%
N/A+72.5%$0.00$54.22M0.00220
CINGW
Cingulate
N/A$0.03
-20.0%
N/A+28.0%$0.00N/A0.0020

Related Companies and Tools


This page (NASDAQ:CEROW) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners